Group One Trading
PLX icon

Group One Trading’s Protalix BioTherapeutics PLX Stock Holding History

Group One Trading’s Portfolio PLX Stock Details PLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$33.4K Buy
+15,400
New +$38.2K ﹤0.01% 5573
2025
Q4 		– Sell
-800
Closed -$1.78K – 8930
2025
Q3 		$1.78K Sell
800
-6,000
-88% -$9.77K ﹤0.01% 7932
2025
Q2 		$10.1K Sell
6,800
-3,000
-31% -$6.14K ﹤0.01% 6713
2025
Q1 		$25.1K Buy
+9,800
New +$23.4K ﹤0.01% 5664
2024
Q2 		– Sell
-2,000
Closed -$2.52K – 7319
2024
Q1 		$2.52K Sell
2,000
-1,000
-33% -$1.49K ﹤0.01% 6434
2023
Q4 		$5.34K Sell
3,000
-100
-3% -$156 ﹤0.01% 6476
2023
Q3 		$5.15K Sell
3,100
-9,400
-75% -$16.9K ﹤0.01% 6694
2023
Q2 		$25K Buy
12,500
+11,900
+1,983% +$28.4K ﹤0.01% 5819
2023
Q1 		$1.26K Sell
600
-6,100
-91% -$10.7K ﹤0.01% 6732
2022
Q4 		$9.18K Sell
6,700
-15,400
-70% -$16.9K ﹤0.01% 6062
2022
Q3 		$23K Sell
22,100
-17,800
-45% -$19.7K ﹤0.01% 5978
2022
Q2 		$43K Sell
39,900
-600
-1% -$702 ﹤0.01% 5693
2022
Q1 		$43K Sell
40,500
-585,700
-94% -$537K ﹤0.01% 6212
2021
Q4 		$521K Buy
626,200
+370,400
+145% +$388K ﹤0.01% 4090
2021
Q3 		$340K Sell
255,800
-58,100
-19% -$88.3K ﹤0.01% 4613
2021
Q2 		$600K Buy
313,900
+305,400
+3,593% +$1.05M ﹤0.01% 4014
2021
Q1 		$38K Buy
8,500
+600
+8% +$2.79K ﹤0.01% 6411
2020
Q4 		$29K Buy
+7,900
New +$28.3K ﹤0.01% 5319
2020
Q3 		– Sell
-2,500
Closed -$9K – 6452
2020
Q2 		$9K Hold
2,500
– – ﹤0.01% 5176
2020
Q1 		$6K Buy
+2,500
New +$8.27K ﹤0.01% 4733
2019
Q4 		– Sell
-22,850
Closed -$47K – 5509
2019
Q3 		$47K Sell
22,850
-5,950
-21% -$17.8K ﹤0.01% 3999
2019
Q2 		$135K Buy
28,800
+140
+0.5% +$592 ﹤0.01% 3118
2019
Q1 		$126K Buy
28,660
+16,760
+141% +$75.5K ﹤0.01% 3014
2018
Q4 		$37K Sell
11,900
-5,910
-33% -$28.1K ﹤0.01% 3712
2018
Q3 		$129K Buy
17,810
+13,510
+314% +$67.8K ﹤0.01% 3342
2018
Q2 		$18K Buy
4,300
+3,700
+617% +$16.4K ﹤0.01% 4408
2018
Q1 		$3K Buy
+600
New +$3.95K ﹤0.01% 4599
2017
Q4 		– Sell
-310
Closed -$2K – 5136
2017
Q3 		$2K Buy
310
+210
+210% +$1.34K ﹤0.01% 4648
2017
Q2 		$1K Sell
100
-420
-81% -$3.94K ﹤0.01% 4643
2017
Q1 		$7K Buy
+520
New +$4.68K ﹤0.01% 4216
2016
Q4 		– Sell
-150
Closed -$1K – 4744
2016
Q3 		$1K Sell
150
-1,000
-87% -$6.24K ﹤0.01% 4445
2016
Q2 		$7K Buy
+1,150
New +$9.19K ﹤0.01% 4189
2015
Q3 		– Sell
-1,800
Closed -$35K – 5114
2015
Q2 		$35K Sell
1,800
-140
-7% -$2.9K ﹤0.01% 3748
2015
Q1 		$35K Buy
1,940
+1,730
+824% +$33.9K ﹤0.01% 3577
2014
Q4 		$4K Sell
210
-12,010
-98% -$258K ﹤0.01% 4547
2014
Q3 		$296K Sell
12,220
-9,950
-45% -$287K ﹤0.01% 2049
2014
Q2 		$809K Sell
22,170
-1,610
-7% -$64.9K 0.01% 1279
2014
Q1 		$1.09M Buy
23,780
+16,940
+248% +$791K 0.02% 1021
2013
Q4 		$266K Sell
6,840
-1,770
-21% -$74.5K ﹤0.01% 2187
2013
Q3 		$390K Buy
8,610
+4,760
+124% +$244K 0.01% 1826
2013
Q2 		$189K Buy
+3,850
New +$204K ﹤0.01% 2224

Other funds holding PLX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MCO
MAK Capital One New York $679M AUM 29.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SWP
Stratos Wealth Partners Beachwood, Ohio $8.8B AUM 21.82% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
PFS
Prospera Financial Services Dallas, Texas $6.89B AUM 37.41% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return

Group One Trading's PLX Position: Q1 2026 in Review

Group One Trading opened a new position in Protalix BioTherapeutics (PLX) in Q1 2026: 13,222 shares worth $28.7K. The stake represents ﹤0.01% of the portfolio and ranks #5703 among its holdings. This is a return to the name: Group One Trading previously reported a position in PLX as recently as Q4 2024.

Group One Trading first reported a position in PLX in Q2 2013 and has held it in 26 quarters since. The position peaked at $551K in Q2 2014. 99 funds tracked by Wall St. Rank hold PLX as of Q1 2026.

  • Group One Trading held 13,222 shares of Protalix BioTherapeutics worth $28.7K as of Q1 2026.
  • Protalix BioTherapeutics was a new Group One Trading position in Q1 2026.
  • Protalix BioTherapeutics made up ﹤0.01% of Group One Trading's portfolio in Q1 2026, its #5703 holding.
  • Group One Trading first reported a position in Protalix BioTherapeutics in Q2 2013 and has held it in 26 quarters since.
  • Group One Trading's Protalix BioTherapeutics position peaked at $551K in Q2 2014.
  • 99 funds tracked by Wall St. Rank held Protalix BioTherapeutics as of Q1 2026.

Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.